ATE182177T1 - Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert - Google Patents

Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert

Info

Publication number
ATE182177T1
ATE182177T1 AT95914255T AT95914255T ATE182177T1 AT E182177 T1 ATE182177 T1 AT E182177T1 AT 95914255 T AT95914255 T AT 95914255T AT 95914255 T AT95914255 T AT 95914255T AT E182177 T1 ATE182177 T1 AT E182177T1
Authority
AT
Austria
Prior art keywords
iii
icerel
cdna
recombinant
interleukin
Prior art date
Application number
AT95914255T
Other languages
English (en)
Inventor
Donald W Nicholson
Ambereen Ali
Neil A Munday
John P Vaillancourt
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Application granted granted Critical
Publication of ATE182177T1 publication Critical patent/ATE182177T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472Cysteine endopeptidases (3.4.22)
    • C12N9/6475Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95914255T 1994-04-08 1995-04-04 Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert ATE182177T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/224,930 US5552536A (en) 1994-04-08 1994-04-08 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)

Publications (1)

Publication Number Publication Date
ATE182177T1 true ATE182177T1 (de) 1999-07-15

Family

ID=22842824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95914255T ATE182177T1 (de) 1994-04-08 1995-04-04 Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert

Country Status (10)

Country Link
US (2) US5552536A (de)
EP (1) EP0759079B1 (de)
JP (1) JP3815572B2 (de)
AT (1) ATE182177T1 (de)
CA (1) CA2187162C (de)
DE (1) DE69510791T2 (de)
DK (1) DK0759079T3 (de)
ES (1) ES2136284T3 (de)
GR (1) GR3031474T3 (de)
WO (1) WO1995027792A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715645B2 (en) * 1994-05-27 2014-05-06 The Regents Of The University Of Colorado Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
FR2723378B1 (fr) * 1994-08-02 1996-10-31 Roussel Uclaf Sequence d'adn codant pour une proteine humaine tx apparentee a l'enzyme de conversion de l'interleukine-1beta, proteine tx, procede de production, compositions pharmaceutiques et leurs applications
US6835555B1 (en) 1994-11-01 2004-12-28 Human Genome Sciences, Inc. Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
US6538121B1 (en) 1994-11-01 2003-03-25 Human Genome Sciences, Inc. Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
US5654146A (en) * 1995-05-31 1997-08-05 Incyte Pharmaceuticals, Inc. Human ice homolog
US6416753B1 (en) * 1996-03-15 2002-07-09 The General Hospital Corporation Method for modulating apoptosis
US5840509A (en) * 1996-07-22 1998-11-24 Eli Lilly And Company Protease and related nucleic acid compounds
US6063600A (en) * 1997-05-23 2000-05-16 Uab Research Foundation DNA encoding canine interleukin-1 receptor antagonist
EP1292697B1 (de) 2000-06-15 2009-07-22 SmithKline Beecham Corporation Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids
EP4082761B1 (de) 2021-04-30 2024-03-27 DB Imagineering BV. Reparaturinjektor mit stützvorrichtung für laminiertes glas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416013A (en) * 1990-04-04 1995-05-16 Sterling Winthrop Inc. Interleukin 1β protease and interleukin 1β protease inhibitors
EP0672151A1 (de) * 1992-06-12 1995-09-20 Massachusetts Institute Of Technology Inhibitoren von ced-3 und verwandte proteine
WO1993025685A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Cloning and characterization of the cell death genes ced-3 and ced-4
AU5102993A (en) * 1992-09-18 1994-04-12 Merck & Co., Inc. Dna encoding murine precursor interleukin 1beta converting enzyme

Also Published As

Publication number Publication date
EP0759079B1 (de) 1999-07-14
EP0759079A1 (de) 1997-02-26
WO1995027792A1 (en) 1995-10-19
CA2187162C (en) 2008-06-17
DK0759079T3 (da) 1999-11-29
GR3031474T3 (en) 2000-01-31
DE69510791D1 (de) 1999-08-19
DE69510791T2 (de) 1999-12-30
ES2136284T3 (es) 1999-11-16
US5760180A (en) 1998-06-02
JP3815572B2 (ja) 2006-08-30
US5552536A (en) 1996-09-03
CA2187162A1 (en) 1995-10-19
JPH09511645A (ja) 1997-11-25

Similar Documents

Publication Publication Date Title
ATE182177T1 (de) Dna, welche für den vorläufer der interleukin-1- beta überführenden enzym-verwandten proteinase iii (ice rel-iii) kodiert
DE3688760D1 (de) Expression von faktor-vii-aktivitaet in saeugetierzellen.
ATE415480T1 (de) B7l-1 moleküle
ATE484587T1 (de) Ldcam genannte moleküle
ATE393227T1 (de) Klonierung und charakterisierung von napsin, einer aspartat-protease
ATE286126T1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
ATE481490T1 (de) Strukturprotein von aav, seine herstellung und verwendung
ATE182176T1 (de) Dna, welche für den vorläufer des interleukin-1 beta konvertierenden enzyms kodiert (ice rel-ii)
DK0700437T3 (da) DNA, der koder for prostaglandin-receptor EP1
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
WO1999043802A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
DE69535232D1 (de) DNA-SEQUENZEN, DIE FÜR DIE MENSCHLICHE PROTEINE Tx UND Ty KODIEREN, DIE ICE GLEICHEN
WO2004060867A3 (en) Secreted protein factor and cell membrane-bound splice variant
ATE266094T1 (de) Produktion des proteins ingap mit hoher expressionsrate
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
NL960017I2 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
SU1147981A1 (ru) Способ определени сульфгидрильных групп в гемсодержащих белках
WO2001096578A3 (en) Protein production in aureobasidium pullulans
EP1074619A3 (de) Promoter für Neuropeptide FF und Anwendung davon für Therapie und Nachweis
MX9804289A (es) Cisteina proteasa similar a la enzima de conversion interleucina-1beta.
DE3483549D1 (de) Stabilisierung von fremdproteinen und plasmide zur verwendung hierfuer.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee